MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202521001143 A) filed by Indoco Remedies Limited on January 06, 2025, for Stable Pharmaceutical Composition Of Alogliptin And Metformin Extended- Release Fixed Dose Combination.
Inventors include Panandikar, Aditi; Inamdar Kavita; Jog Sunil; Bhide Yogesh; and Khairnar Swapnil.
The application for the patent was published on July 10, 2026, under issue no. 28/2026.
Abstract: The present invention relates to an extended-release pharmaceutical composition comprising Alogliptin or its pharmaceutically acceptable salt thereof, Metformin or its pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients. The present invention relates to an extended-release pharmaceutical composition comprising Alogliptin or its pharmaceutically acceptable salt thereof, Metformin or its pharmaceutically acceptable salt thereof and one or pharmaceutically acceptable excipients, wherein Metformin is present in the extended-release form. In another aspect, the present invention relates to an extended-release pharmaceutical composition comprising Alogliptin or its pharmaceutically acceptable salt thereof, Metformin or its pharmaceutically acceptable salt thereof and one or pharmaceutically acceptable excipients, wherein the composition is used for the treatment of diabetes.
Disclaimer: Curated by HT Syndication.
